02/28/2026
Somewhere along the way, we started calling metabolic dysfunction “normal.”
Central weight gain.
Insulin resistance.
Elevated triglycerides.
Fatty liver.
High CRP.
Brain fog.
PCOS.
Hypertension.
Metabolic syndrome is chronic cellular inflammation.
GLP-1 receptor agonists were originally approved for diabetes and weight management.
But the data now shows something deeper.
These medications influence:
• Inflammatory cytokines
• Insulin sensitivity
• Endothelial function
• Visceral fat reduction
• Cardiovascular risk markers
This isn’t just about weight loss.
It’s about restoring metabolic signaling.
At Henoch Med, we evaluate labs comprehensively and use GLP-1 therapy thoughtfully — when clinically appropriate — to reduce systemic inflammation and improve cardiometabolic health.
Because common does not mean normal.
Book online
henochmed.com
785-202-5829